Skip to main content
. 2006 Apr;44(4):1335–1341. doi: 10.1128/JCM.44.4.1335-1341.2006

TABLE 4.

German syphilis proficiency testing program 2000 to 2003: accuracy of test results for the most frequently used commercially manufactured VDRL and FTA-ABS IgM testsa

Assay Manufacturer Qualitative testing
Quantitative testing
No. of participants Correct results (%) No. of participants Correct results (%)
VDRL AX 31 (4.3) 89.1 (15.0) 30 (5.2) 73.8 (15.3)
BN 5 (1.0) 93.8 (16.5) 5 (0.5) 56.7 (24.0)
IS 32 (6.7) 88.3 (15.9) 29 (7.0) 71.1 (9.9)
BB 14 (2.7) 81.5 (14.9) 13 (2.5) 72.7 (13.6)
BW 74 (7.7) 91.7 (6.9) 74 (9.6) 73.6 (5.5)
ZZ 17 (4.2) 88.1 (13.7) 23 (6.9) 65.8 (17.8)
Total 177 (13) 89.6 (10.4) 179 (20) 71.1 (7.5)
FTA-ABS IgM AX 29 (3.9) 83.8 (14.2) 19 (3.5) 70.5 (13.7)
IS 12 (3.8) 89.7 (9.2) 7 (2.5) 69.8 (18.3)
BA 5 (1.4) 92.4 (12.6) 4 (1.6) 75.2 (20.7)
MA 22 (3.3) 79.8 (12.4) 9 (2.1) 48.9 (28.7)
ZZ 14 (3.8) 74.3 (21.1) 11 (2.6) 58.9 (27.7)
Total 84 (11) 82.3 (11.5) 54 (8) 64.9 (18.0)
a

Results are means, with standard deviations indicated in parentheses. AX, bioMerieux; BA, BAG; BB, Biokit: BN, Becton-Dickinson; BW, DadeBehring; IS, Innogenetics; MA, Mast; ZZ, other.